Clinical trial · no report yet · Phase 3
NEOPAN
A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma
- NCT02539537 ↗
- Completed
- UNICANCER
- 14 commentary sources found
- Standard
We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Commentary we found
Podcasts, YouTube videos and X posts in our index that name this trial. A report screens them, searches for more and cites what clinicians said when it is built.
| Channel | Found | |
|---|---|---|
| X threads | 11 | |
| YouTube | 3 |
The trial
ClinicalTrials.gov- Official title
- A Randomized Phase III Trial Comparing Chemotherapy With Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma
- Phase
- Phase 3
- Status
- Completed
- Conditions
- Pancreatic Cancer; Carcinoma
- Interventions
- Gemcitabine; Folinic Acid; 5-Fluoro-uracil; Oxaliplatin; Irinotecan; L-folinic
- Arms
- Arm A: Gemcitabine · Active comparator
- Arm B: Folfirinox · Experimental
- Enrollment
- 171
- Primary outcomes
- Progression-Free-Survival (PFS)
- Sponsor
- UNICANCER
- Start
- Oct 23, 2015
- Primary completion
- Feb 2022
- Results posted
- No
- Registry record
- NCT02539537 · updated Jan 9, 2024
Publications
linked from the registry- Ducreux M, Desgrippes R, Rinaldi Y, Di Fiore F, Guimbaud R, Evesque L, Bachet JB, Vanelslander P, Lecomte T, Capitain O, Parzy A, Bolliet M, Etienne PL, Forestier J, El Hajbi F, Bignon AL, Lebrun-Ly V, De Sousa Carvalho N, Texier M, Bouche O. PRODIGE 29-UCGI 26 (NEOPAN): A Phase III Randomized Trial Comparing Chemotherapy With FOLFIRINOX or Gemcitabine in Locally Advanced Pancreatic Carcinoma. J Clin Oncol. 2025 Jul 10;43(20):2255-2264. doi: 10.1200/JCO-24-02210. Epub 2025 May 16. PubMed 40378359